Voriconazole News and Research

RSS
Voriconazole is a drug that treats infections caused by fungi.
Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

New multicenter trial achieves 71% survival in AML children

New multicenter trial achieves 71% survival in AML children

Gilead Sciences doses first patient in Quad Phase III clinical program

Gilead Sciences doses first patient in Quad Phase III clinical program

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

FDA grants approval for Abbott's antiretroviral medication Norvir

FDA grants approval for Abbott's antiretroviral medication Norvir

Heilongjiang Tianlong Pharmaceutical changes R&D focus to antibiotics and cardiac drugs

Heilongjiang Tianlong Pharmaceutical changes R&D focus to antibiotics and cardiac drugs

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

FDA: Plavix-Prilosec combination may reduce anti-clotting effect

FDA: Plavix-Prilosec combination may reduce anti-clotting effect

Mylan Pharmaceuticals and Matrix Laboratories enter into license agreement with Pfizer

Mylan Pharmaceuticals and Matrix Laboratories enter into license agreement with Pfizer

Voriconazole effective in combating fungal infections

Voriconazole effective in combating fungal infections

Pfizer receives FDA approval for Eraxis to treat candidemia

Pfizer receives FDA approval for Eraxis to treat candidemia

Study proves the effectiveness of Vfend for the treatment of candidemia

Study proves the effectiveness of Vfend for the treatment of candidemia

FDA reinforces use of Sustiva in first-line HIV combination therapy

FDA reinforces use of Sustiva in first-line HIV combination therapy